Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations

Published:2022-07 Issue:7 Volume:7 Page:1463-1476
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Yau Kevin^ORCID,Dharia Atit,Alrowiyti Ibrahim,Cherney David Z.I.

Publisher

Elsevier BV

Subject

Nephrology

Reference104 articles.

1. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N Engl J Med,2018

2. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

3. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

4. Cardiovascular outcomes with ertugliflozin in type 2 diabetes;Cannon;N Engl J Med,2020

5. 10-Year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthcare Costs Across Diabetic Kidney Disease Stages: A Veterans Affairs Study;Kidney Medicine;2024-09

2. Metabolism and bioenergetics in the pathophysiology of organ fibrosis;Free Radical Biology and Medicine;2024-09

3. Pharmacovigilance study for SGLT 2 inhibitors- Safety review of real-world data & randomized clinical trials;Current Problems in Cardiology;2024-09

4. Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database;Acta Diabetologica;2024-08-29

5. Potential impact of sodium glucose co-transporter (SGLT2) inhibitors on cholesterol fractions in stage 3 chronic kidney disease;The Egyptian Journal of Internal Medicine;2024-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3